Hot share tips and all the big AIM exposes from the City's most-connected reporters
By Steve Moore | Monday 4 December 2017
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Intercede (IGP) has announced “a contract with a UK Government Ministerial department”, following half-year results and “a contract with a large European bank” last week…
The latest contract sees the company stating “Intercede's MyID will enable this customer to eliminate a reliance on the use of potentially insecure passwords for secure authentication” and “financially, the new contract will generate revenue for the group of around £250,000 in the current financial year and potentially up to £500,000 in the following year”.
This follows the European bank contract to “supply its MyID product for over 10,000 employees in addition to recurring support and maintenance services. The deal is worth more than £250,000 over a three-year period with most of the value accruing in the first 12 months of the contract period”.
These though come after results for the six months ended 30th September 2017 showed a £1.3 million decline in net current assets to £2.7 million and there also (a £0.6 million increased) £4.8 million of non-current liabilities. Non-current (property, plant and equipment) assets were just £0.6 million – meaning a £1.5 million net liabilities position.
Gross cash was £4.8 million, though that more than £2 million down and with the other liabilities and customer delays it looks to be a question of when’s it discounted fundraising ahoy? My stance remains sell / avoid.
Never miss a story.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Comments are turned off for this article.
Search ShareProphets |
Stock market news |
Recent Comments |